<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="Content-Security-Policy" content="script-src 'none'">
    <title>NIAID News (@NIAIDNews)</title>
    <style>
      body {
        font-family: Arial, Helvetica, sans-serif;
        max-width: 800px;
      }
      .profile {
        font-height: 24px;
        font-weight: bold;
        margin-left: 4px;
      }
      .profile img {
        height: 24px;
        width: 24px;
      }
      .profile .user { color: #888 }
      .tweet .head {
        font-weight: bold;
        margin: 8px;
      }
      .tweet .head .id { display: none }
      .tweet .head .user { color: #888 }
      .tweet .head .time { margin-left: 12px }
      .tweet .head a {
        color: black;
        text-decoration: none;
      }
      .tweet .content { margin: 4px }
      .tweet .content img, .tweet .content svg {
        max-height: 300px;
        max-width: 300px;
      }
      .tweet .text { display: none }
      .tweet hr { border: solid 1px #ddd }
      .sep { border: solid 1px black }
    </style>
  </head>
  <body>
    <div class="profile">
      <img src="https://pbs.twimg.com/profile_images/915948170303111169/VQKi3e_U_normal.jpg"> NIAID News 
      <span class="user">@NIAIDNews</span>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344694563181481985"><span class="id">1344694563181481985</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-31 13:19:01</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NEWS: NIAID scientists further validate 
            <a dir="ltr" href="https://twitter.com/hashtag/RTQuIC?src=hashtag_click">#RTQuIC</a> test to diagnose 
            <a dir="ltr" href="https://twitter.com/hashtag/Parkinson?src=hashtag_click">#Parkinson</a>‚Äôs disease.
            Spinal fluid sample yields result in 1-2 days with high accuracy.
          </div>
          <hr>
          <br><a href="https://t.co/JkHnJm6ojc?amp=1">
          <div>
            <img alt src="https://pbs.twimg.com/card_img/1342795338390806531/KBVehzQz?format=jpg&name=240x240">
          </div>
          </a><a href="https://t.co/JkHnJm6ojc?amp=1">
          <div>
            <div dir="auto">
              <b>A rapid Œ±‚Äêsynuclein seed assay of Parkinson‚Äôs disease CSF panel shows high diagnostic accuracy</b>
            </div>
            <div dir="auto">
              Background Assays that specifically measure Œ±‚Äêsynuclein seeding activity in biological fluids could
              revolutionize the diagnosis of Parkinson‚Äôs disease. Recent improvements in Œ±‚Äêsynuclein real‚Äêtime...
            </div>
            <div dir="auto">
              <i>onlinelibrary.wiley.com</i>
            </div>
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NEWS: NIAID scientists further validate #RTQuIC test to diagnose #Parkinson ‚Äôs disease. Spinal fluid sample
        yields result in 1-2 days with high accuracy. A rapid Œ±‚Äêsynuclein seed assay of Parkinson‚Äôs disease CSF
        panel shows high diagnostic accuracy Background Assays that specifically measure Œ±‚Äêsynuclein seeding activity
        in biological fluids could revolutionize the diagnosis of Parkinson‚Äôs disease. Recent improvements in
        Œ±‚Äêsynuclein real‚Äêtime... onlinelibrary.wiley.com
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344691367339933697"><span class="id">1344691367339933697</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-31 13:06:19</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NEJM paper details mRNA-1273 vaccine's 94.1% efficacy in preventing symptomatic COVID-19 when tested in
            Phase 3 clinical trial. Vaccine co-developed by Moderna and NIH also effective at preventing severe
            COVID-19. Study findings at: DOI: 10.1056/NEJMoa2035389 (2020).
          </div>
        </div>
      </div>
      <div class="text">
        NEJM paper details mRNA-1273 vaccine's 94.1% efficacy in preventing symptomatic COVID-19 when tested in Phase 3
        clinical trial. Vaccine co-developed by Moderna and NIH also effective at preventing severe COVID-19. Study
        findings at: DOI: 10.1056/NEJMoa2035389 (2020).
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344282091098259457"><span class="id">1344282091098259457</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-30 10:00:00</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/ScienceHighlights2020?src=hashtag_click">#ScienceHighlights2020</a>
            üî¨: This year, researchers made enormous strides in understanding, preventing &amp; treating 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a>. Other work brought
            scientific advances in <a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click">#HIV</a>, 
            <a dir="ltr" href="https://twitter.com/hashtag/tuberculosis?src=hashtag_click">#tuberculosis</a>, 
            <a dir="ltr" href="https://twitter.com/hashtag/eczema?src=hashtag_click">#eczema</a> &amp; many additional
            areas: <a dir="ltr" href="https://t.co/0XB3M9qiAZ?amp=1">http://bit.ly/2020NIAIDHighlights‚Ä¶</a>
          </div>
          <hr>
          <br>
          <video preload="auto" playsinline aria-label="Embedded video"
              poster="https://pbs.twimg.com/tweet_video_thumb/Eqa1k2pXEAYttK-.jpg"
              src="https://video.twimg.com/tweet_video/Eqa1k2pXEAYttK-.mp4" type="video/mp4" controls>
          </video>
          <div dir="auto">GIF</div>
        </div>
      </div>
      <div class="text">
        #ScienceHighlights2020 üî¨ : This year, researchers made enormous strides in understanding, preventing &amp;
        treating #COVID19 . Other work brought scientific advances in #HIV , #tuberculosis , #eczema &amp; many
        additional areas: http:// bit.ly/2020NIAIDHighl ights ‚Ä¶ GIF
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024492306120704"><span class="id">1344024492306120704</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:24</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> is the 1st product
            discovered and developed by NIAID‚Äôs Vaccine Research Center to receive 
            <a dir="ltr" href="https://twitter.com/FDA">@FDA</a> license approval and builds upon tools and experience
            from HIV research. VRC integrates research, process development, manufacturing, clinical testing and sample
            evaluation.
          </div>
        </div>
      </div>
      <div class="text">
        #Ebanga is the 1st product discovered and developed by NIAID‚Äôs Vaccine Research Center to receive @FDA license
        approval and builds upon tools and experience from HIV research. VRC integrates research, process development,
        manufacturing, clinical testing and sample evaluation.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024491190435841"><span class="id">1344024491190435841</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:24</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> was licensed to
            Ridgeback Biotherapeutics in Dec. 2018. Ridgeback and <a dir="ltr" href="https://twitter.com/BARDA">@BARDA</a>
            partnered in September 2019 for late-stage manufacturing and regulatory activities to support licensure. 
            <a dir="ltr" href="https://t.co/MC6QX6YsXd?amp=1">https://medicalcountermeasures.gov/newsroom/2020/ridgeback/‚Ä¶</a>
          </div>
        </div>
      </div>
      <div class="text">
        #Ebanga was licensed to Ridgeback Biotherapeutics in Dec. 2018. Ridgeback and @BARDA partnered in September 2019
        for late-stage manufacturing and regulatory activities to support licensure. https://
        medicalcountermeasures.gov/newsroom/2020/ ridgeback/ ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024489768615937"><span class="id">1344024489768615937</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:23</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            The <a dir="ltr" href="https://twitter.com/hashtag/PALM?src=hashtag_click">#PALM</a> trial ended early (in
            Aug 2019) due to data showing patients receiving 
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> or REGN-EB3 (Inmazeb)
            had a greater chance of surviving Ebola virus disease. The findings were confirmed in a Nov. 2019
            publication <a dir="ltr" href="https://t.co/8ZmMQHsyr7?amp=1">https://niaid.nih.gov/news-events/investigational-drugs-reduce-risk-death-ebola-virus-disease‚Ä¶</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1344024489768615937/photo/1">
          <div>
            <img
                alt="PALM trial logo: the words pamoja tulinde maisha; together save lives; ensemble sauvons les vies surround a drawing of people holding hands in a circle around a tree"
                src="https://pbs.twimg.com/media/EqbrtoKUcAAAKLr?format=png&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        The #PALM trial ended early (in Aug 2019) due to data showing patients receiving #Ebanga or REGN-EB3 (Inmazeb)
        had a greater chance of surviving Ebola virus disease. The findings were confirmed in a Nov. 2019 publication
        https:// niaid.nih.gov/news-events/in vestigational-drugs-reduce-risk-death-ebola-virus-disease ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024487742717952"><span class="id">1344024487742717952</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:23</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            In Aug. 2018, the <a dir="ltr" href="https://twitter.com/hashtag/DRC?src=hashtag_click">#DRC</a> declared
            the country‚Äôs 10th outbreak of <a dir="ltr" href="https://twitter.com/hashtag/EVD?src=hashtag_click">#EVD</a>.
            In Nov. 2018, <a dir="ltr" href="https://twitter.com/inrb_kinshasa">@inrb_kinshasa</a> and 
            <a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click">#NIAID</a> (with 
            <a dir="ltr" href="https://twitter.com/WHO">@WHO</a> support) began a randomized, controlled trial of
            multiple investigational Ebola therapies, including 
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a>, in the 
            <a dir="ltr" href="https://twitter.com/hashtag/DRC?src=hashtag_click">#DRC</a>. 
            <a dir="ltr" href="https://t.co/ZEaMzAz7dB?amp=1">https://niaid.nih.gov/news-events/clinical-trial-investigational-ebola-treatments-begins-democratic-republic-congo‚Ä¶</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1344024487742717952/photo/1">
          <div>
            <img alt="portable treatment cubes at an Ebola treatment center in Beni"
                src="https://pbs.twimg.com/media/EqbpJBCVQAA5jp4?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        In Aug. 2018, the #DRC declared the country‚Äôs 10th outbreak of #EVD . In Nov. 2018, @inrb_kinshasa and #NIAID
        (with @WHO support) began a randomized, controlled trial of multiple investigational Ebola therapies, including
        #Ebanga , in the #DRC . https:// niaid.nih.gov/news-events/cl
        inical-trial-investigational-ebola-treatments-begins-democratic-republic-congo ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024484337000448"><span class="id">1344024484337000448</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:22</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            In May 2018, NIAID (with <a dir="ltr" href="https://twitter.com/DARPA">@DARPA</a> support) began enrolling
            healthy volunteers in a Phase 1 clinical trial of 
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> at the 
            <a dir="ltr" href="https://twitter.com/NIHClinicalCntr">@NIHClinicalCntr</a>. Results published in Jan. 2019
            showed the therapy is safe, well-tolerated, and easy to administer. 
            <a dir="ltr" href="https://t.co/cSVobDBPIQ?amp=1">https://niaid.nih.gov/news-events/investigational-monoclonal-antibody-treat-ebola-safe-adults‚Ä¶</a>
          </div>
        </div>
      </div>
      <div class="text">
        In May 2018, NIAID (with @DARPA support) began enrolling healthy volunteers in a Phase 1 clinical trial of
        #Ebanga at the @NIHClinicalCntr . Results published in Jan. 2019 showed the therapy is safe, well-tolerated, and
        easy to administer. https:// niaid.nih.gov/news-events/in
        vestigational-monoclonal-antibody-treat-ebola-safe-adults ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024483124768768"><span class="id">1344024483124768768</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:22</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            Together with <a dir="ltr" href="https://twitter.com/MTamfum">@MTamfum</a>, 
            <a dir="ltr" href="https://twitter.com/inrb_kinshasa">@inrb_kinshasa</a> &amp; the Institute for Research in
            Biomedicine (Switzerland), Dr. Nancy Sullivan &amp; her team at NIAID‚Äôs VRC isolated 
            <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> from a survivor of the
            1995 Kikwit Ebola outbreak. Preclinical studies showed promise: 
            <a dir="ltr" href="https://t.co/Aq0mYgvGZl?amp=1">https://niaid.nih.gov/news-events/experimental-ebola-antibody-protects-monkeys‚Ä¶</a>
          </div>
        </div>
      </div>
      <div class="text">
        Together with @MTamfum , @inrb_kinshasa &amp; the Institute for Research in Biomedicine (Switzerland), Dr. Nancy
        Sullivan &amp; her team at NIAID‚Äôs VRC isolated #Ebanga from a survivor of the 1995 Kikwit Ebola outbreak.
        Preclinical studies showed promise: https:// niaid.nih.gov/news-events/ex
        perimental-ebola-antibody-protects-monkeys ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024482059448321"><span class="id">1344024482059448321</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:21</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            A longstanding research partnership between 
            <a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click">#NIAID</a> scientists and their
            collaborators in the Democratic Republic of the Congo (<a dir="ltr"
            href="https://twitter.com/hashtag/DRC?src=hashtag_click">#DRC</a>) made this significant achievement
            possible.
          </div>
        </div>
      </div>
      <div class="text">
        A longstanding research partnership between #NIAID scientists and their collaborators in the Democratic Republic
        of the Congo ( #DRC ) made this significant achievement possible.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024480926978048"><span class="id">1344024480926978048</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-29 16:56:21</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/EBOLA?src=hashtag_click">#EBOLA</a> NEWS: Last week, 
            <a dir="ltr" href="https://twitter.com/FDA">@FDA</a> approved a single human monoclonal antibody now known
            as <a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click">#Ebanga</a> (Ansuvimab-zykl, 
            <a dir="ltr" href="https://twitter.com/hashtag/mAb114?src=hashtag_click">#mAb114</a>), for the treatment for
            Zaire ebolavirus (Ebolavirus) infection in adults and children.
          </div>
          <hr>
          <br><a href="https://t.co/VZiH1Rrq0y?amp=1">
          <div>
            <img alt src="https://pbs.twimg.com/card_img/1341523775787954176/CQ_3fVrz?format=png&name=small">
          </div>
          </a><a href="https://t.co/VZiH1Rrq0y?amp=1">
          <div>
            <div dir="auto">
              <b>FDA Approves Treatment for Ebola Virus</b>
            </div>
            <div dir="auto">
              The FDA approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire
              ebolavirus (Ebolavirus) infection in adults and children.
            </div>
            <div dir="auto">
              <i>fda.gov</i>
            </div>
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        #EBOLA NEWS: Last week, @FDA approved a single human monoclonal antibody now known as #Ebanga (Ansuvimab-zykl,
        #mAb114 ), for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children. FDA Approves
        Treatment for Ebola Virus The FDA approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the
        treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children. fda.gov
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1343574559874666497"><span class="id">1343574559874666497</span> NIH <span
        class="user">@NIH</span><span class="time">2020-12-28 11:08:32</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH/status/1343574559874666497">NIH (@NIH)</a></b>
          <br>
          <div lang="en" dir="auto">News: Phase 3 trial of Novavax investigational COVID-19 vaccine opens</div>
          <hr>
          <br><a href="https://t.co/ApJW4gcfeF?amp=1">
          <div>
            <img alt src="https://pbs.twimg.com/card_img/1343633016548110336/dTH0wX1k?format=jpg&name=small">
          </div>
          </a><a href="https://t.co/ApJW4gcfeF?amp=1">
          <div>
            <div dir="auto">
              <b>Phase 3 trial of Novavax investigational COVID-19 vaccine opens</b>
            </div>
            <div dir="auto">NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.</div>
            <div dir="auto">
              <i>nih.gov</i>
            </div>
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH (@NIH) News: Phase 3 trial of Novavax investigational COVID-19 vaccine opens Phase 3 trial of Novavax
        investigational COVID-19 vaccine opens NIH- and BARDA-funded trial will enroll up to 30,000 volunteers. nih.gov
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341744766287970305"><span class="id">1341744766287970305</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-23 09:57:35</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            COVID-19 NEWS: now published in <a dir="ltr" href="https://twitter.com/NEJM">@NEJM</a>: results of a
            clinical trial testing LY-CoV555 in hospitalized 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> patients showed that
            it did not provide clinical benefit compared to placebo in that patient population. 
            <a dir="ltr" href="https://t.co/y3z6NLTdaU?amp=1">http://bit.ly/38wv2Je</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1341744766287970305/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/Ep7Vp5OUwAA8kxr?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        COVID-19 NEWS: now published in @NEJM : results of a clinical trial testing LY-CoV555 in hospitalized #COVID19
        patients showed that it did not provide clinical benefit compared to placebo in that patient population. http://
        bit.ly/38wv2Je
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1341222910065692675"><span class="id">1341222910065692675</span> NIH <span
        class="user">@NIH</span><span class="time">2020-12-21 23:23:55</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH/status/1341222910065692675">NIH (@NIH)</a></b>
          <br>
          <div lang="en" dir="auto">
            Historic event LIVE tomorrow (12/22) @ 10 am ET on 
            <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a>‚Äôs Twitter. Front-line
            workers from <a dir="ltr" href="https://twitter.com/NIHClinicalCntr">@NIHClinicalCntr</a>, 
            <a dir="ltr" href="https://twitter.com/NIHDirector">@NIHDirector</a>, 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> Director Dr. Anthony Fauci, &amp; 
            <a dir="ltr" href="https://twitter.com/SecAzar">@SecAzar</a> will 
            <a dir="ltr" href="https://twitter.com/hashtag/SleeveUp?src=hashtag_click">#SleeveUp</a> to receive 
            <a dir="ltr" href="https://twitter.com/moderna_tx">@moderna_tx</a>‚Äôs 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> vaccine, co-developed
            by NIH. <a dir="ltr" href="https://t.co/FehuOhbDJR?amp=1">http://bit.ly/3hbXLXM</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH/status/1341222910065692675/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/Epz6XOeUwAEFNnM?format=png&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH (@NIH) Historic event LIVE tomorrow (12/22) @ 10 am ET on #NIH ‚Äôs Twitter. Front-line workers from
        @NIHClinicalCntr , @NIHDirector , @NIAIDNews Director Dr. Anthony Fauci, &amp; @SecAzar will #SleeveUp to
        receive @moderna_tx ‚Äôs #COVID19 vaccine, co-developed by NIH. http:// bit.ly/3hbXLXM
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341135816584798208"><span class="id">1341135816584798208</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-21 17:37:50</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            .<a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> scientists demonstrate deep phenotyping of
            human tissues using IBEX and commercially available antibodies by visualizing 
            <a dir="ltr" href="https://twitter.com/hashtag/immune?src=hashtag_click">#immune</a> interactions in a
            mesenteric <a dir="ltr" href="https://twitter.com/hashtag/LymphNode?src=hashtag_click">#LymphNode</a> with 
            <a dir="ltr" href="https://twitter.com/hashtag/GerminalCenters?src=hashtag_click">#GerminalCenters</a>:
          </div>
          <hr>
          <br>
          <video preload="none" playsinline aria-label="Embedded video"
              poster="https://pbs.twimg.com/ext_tw_video_thumb/1341135734565167104/pu/img/Db4r4SK1YSElWRUm.jpg"
              src="blob:https://twitter.com/a4cbdd3b-3ea2-4374-9f5b-78d75372cd44">
          </video>
        </div>
      </div>
      <div class="text">
        . @NIAIDNews scientists demonstrate deep phenotyping of human tissues using IBEX and commercially available
        antibodies by visualizing #immune interactions in a mesenteric #LymphNode with #GerminalCenters :
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341135313553534976"><span class="id">1341135313553534976</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-21 17:35:50</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            IBEX can be applied to capture ultra-high content data from human tissues, as 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> scientists demonstrate by visualizing 
            <a dir="ltr" href="https://twitter.com/hashtag/tumor?src=hashtag_click">#tumor</a>-<a dir="ltr"
            href="https://twitter.com/hashtag/immune?src=hashtag_click">#immune</a> interactions in a pancreatic 
            <a dir="ltr" href="https://twitter.com/hashtag/LymphNode?src=hashtag_click">#LymphNode</a> with 
            <a dir="ltr" href="https://twitter.com/hashtag/metastatic?src=hashtag_click">#metastatic</a> lesions:
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1341135313553534976/photo/1">
          <div>
            <img
                alt="Images from IBEX experiments in a human tissue sample from a pancreatic lymph node with metastatic lesions."
                src="https://pbs.twimg.com/media/EpyrYTlW4AEGxDY?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        IBEX can be applied to capture ultra-high content data from human tissues, as @NIAIDNews scientists demonstrate
        by visualizing #tumor - #immune interactions in a pancreatic #LymphNode with #metastatic lesions:
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341134969712861189"><span class="id">1341134969712861189</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-21 17:34:28</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NEWS: <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> researchers have developed a new 
            <a dir="ltr" href="https://twitter.com/hashtag/OpenSource?src=hashtag_click">#OpenSource</a> method for
            highly <a dir="ltr" href="https://twitter.com/hashtag/multiplex?src=hashtag_click">#multiplex</a> tissue
            imaging, called IBEX, that can be integrated into most current lab workflows. Read more in 
            <a dir="ltr" href="https://twitter.com/PNASNews">@PNASNews</a>: 
            <a dir="ltr" href="https://t.co/YBuqq7eSzL?amp=1">http://bit.ly/IBEX-PNAS</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1341134969712861189/photo/1">
          <div>
            <img alt="Confocal images from IBEX experiments with various mouse organs."
                src="https://pbs.twimg.com/media/EpyrCLIWwAMwWnZ?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NEWS: @NIAIDNews researchers have developed a new #OpenSource method for highly #multiplex tissue imaging,
        called IBEX, that can be integrated into most current lab workflows. Read more in @PNASNews : http://
        bit.ly/IBEX-PNAS
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/SecAzar/status/1341117012064559104"><span class="id">1341117012064559104</span>
        Secretary Alex Azar <span class="user">@SecAzar</span><span class="time">2020-12-21 16:23:07</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/SecAzar/status/1341117012064559104">Secretary Alex Azar (@SecAzar)</a></b>
          <br>
          <div lang="en" dir="auto">
            Tomorrow I'll receive my COVID-19 vaccine <a dir="ltr" href="https://twitter.com/NIH">@NIH</a> alongside 
            <a dir="ltr" href="https://twitter.com/NIHDirector">@NIHDirector</a>, 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> Dr. Fauci, &amp; several 
            <a dir="ltr" href="https://twitter.com/NIHClinicalCntr">@NIHClinicalCntr</a> frontline workers.
            <br>
            <br>We believe it's important to publicly receive the vaccine as part of our efforts to demonstrate that
            these vaccines are safe and effective.
          </div>
        </div>
      </div>
      <div class="text">
        Secretary Alex Azar (@SecAzar) Tomorrow I'll receive my COVID-19 vaccine @NIH alongside @NIHDirector ,
        @NIAIDNews Dr. Fauci, &amp; several @NIHClinicalCntr frontline workers. We believe it's important to publicly
        receive the vaccine as part of our efforts to demonstrate that these vaccines are safe and effective.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIHDirector/status/1341116991525056519"><span class="id">1341116991525056519</span>
        Francis S. Collins <span class="user">@NIHDirector</span><span class="time">2020-12-21 16:23:02</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIHDirector/status/1341116991525056519">Francis S. Collins (@NIHDirector)</a></b>
          <br>
          <div lang="en" dir="auto">
            I will receive <a dir="ltr" href="https://twitter.com/moderna_tx">@moderna_tx</a>
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> vaccine alongside 
            <a dir="ltr" href="https://twitter.com/SecAzar">@SecAzar</a>, 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> Dr. Fauci, and several 
            <a dir="ltr" href="https://twitter.com/NIHClinicalCntr">@NIHClinicalCntr</a> frontline workers as part of an
            NIH vaccine kick-off event tomorrow <a dir="ltr" href="https://twitter.com/10amet">@10amET</a>. We at 
            <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a> are proud to have taken part
            in an amazing journey that will save many lives.
          </div>
        </div>
      </div>
      <div class="text">
        Francis S. Collins (@NIHDirector) I will receive @moderna_tx #COVID19 vaccine alongside @SecAzar , @NIAIDNews
        Dr. Fauci, and several @NIHClinicalCntr frontline workers as part of an NIH vaccine kick-off event tomorrow
        @10amET . We at #NIH are proud to have taken part in an amazing journey that will save many lives.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341116712519757824"><span class="id">1341116712519757824</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-21 16:21:55</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get 
            <a dir="ltr" href="https://twitter.com/moderna_tx">@moderna_tx</a>
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> vaccine alongside 
            <a dir="ltr" href="https://twitter.com/SecAzar">@SecAzar</a>, 
            <a dir="ltr" href="https://twitter.com/NIHDirector">@NIHDirector</a>, and several 
            <a dir="ltr" href="https://twitter.com/NIHClinicalCntr">@NIHClinicalCntr</a> frontline workers to build
            confidence in the vaccine, which is the best hope against this pandemic.
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1341116712519757824/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EpyZbjhUUAIkTXx?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get @moderna_tx #COVID19 vaccine
        alongside @SecAzar , @NIHDirector , and several @NIHClinicalCntr frontline workers to build confidence in the
        vaccine, which is the best hope against this pandemic.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341114742060929025"><span class="id">1341114742060929025</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-21 16:14:05</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NEWS: NIAID scientists suggest <a dir="ltr" href="https://twitter.com/hashtag/Reston?src=hashtag_click">#Reston</a>
            <a dir="ltr" href="https://twitter.com/hashtag/ebolavirus?src=hashtag_click">#ebolavirus</a> be considered a
            livestock pathogen with potential to affect other mammals, including people, based on a new study of pigs. 
            <a dir="ltr" href="https://t.co/zu07sOgyzD?amp=1">https://bit.ly/3h7SEHM</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1341114742060929025/photo/1">
          <div>
            <img
                alt="This colorized transmission electron micrograph shows a slice of Reston virus particles (blue) in the lung of an infected pig."
                src="https://pbs.twimg.com/media/EpyYni1VgAAGbjS?format=png&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NEWS: NIAID scientists suggest #Reston #ebolavirus be considered a livestock pathogen with potential to affect
        other mammals, including people, based on a new study of pigs. https:// bit.ly/3h7SEHM
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1340132239045058560"><span class="id">1340132239045058560</span> NIH <span
        class="user">@NIH</span><span class="time">2020-12-18 23:09:58</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH/status/1340132239045058560">NIH (@NIH)</a></b>
          <br>
          <div lang="en" dir="auto">
            Today <a dir="ltr" href="https://twitter.com/US_FDA">@US_FDA</a> granted Emergency Use Authorization to 
            <a dir="ltr" href="https://twitter.com/moderna_tx">@moderna_tx</a> for 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> vaccine mRNA-1273. We
            are proud of the work by scientists at 
            <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a>'s 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDnews</a> who co-developed this urgently needed
            vaccine. <a dir="ltr" href="https://t.co/1LqivvTwXS?amp=1">http://bit.ly/38oqHb4</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH/status/1340132239045058560/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EpkbAJcUUAEefZ7?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH (@NIH) Today @US_FDA granted Emergency Use Authorization to @moderna_tx for #COVID19 vaccine mRNA-1273. We
        are proud of the work by scientists at #NIH 's @NIAIDnews who co-developed this urgently needed vaccine. http://
        bit.ly/38oqHb4
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1339671063844667392"><span class="id">1339671063844667392</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-17 16:37:26</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> began enrolling
            participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal 
            <a dir="ltr" href="https://twitter.com/hashtag/antibody?src=hashtag_click">#antibody</a> therapeutics in
            hospitalized participants. <a dir="ltr" href="https://t.co/iWgSCbSnCC?amp=1">http://bit.ly/ACTIV3-GSK-VIR-Brii‚Ä¶</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1339671063844667392/photo/1">
          <div>
            <img
                alt="A scanning electron micrograph shows an apopototic cell (colored red) heavily infected with SARS-CoV-2 virus particles (colored yellow)"
                src="https://pbs.twimg.com/media/Epd2qg-VEAELFLS?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for #COVID19 began enrolling
        participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal #antibody therapeutics
        in hospitalized participants. http:// bit.ly/ACTIV3-GSK-VIR -Brii ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656"><span class="id">1339608777452998656</span>
        NIH Common Fund <span class="user">@NIH_CommonFund</span><span class="time">2020-12-17 12:29:55</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656">NIH Common Fund (@NIH_CommonFund)</a></b>
          <br>
          <div lang="en" dir="auto">
            Heard about our Cellular Senescence Network (<a dir="ltr"
            href="https://twitter.com/hashtag/SenNet?src=hashtag_click">#SenNet</a>) program? It aims to identify &amp;
            characterize senescent cells (which no longer replicate) across the body &amp; develop technology for
            studying <a dir="ltr" href="https://twitter.com/hashtag/senescence?src=hashtag_click">#senescence</a>. Read
            more on the <a dir="ltr" href="https://twitter.com/hashtag/NIHCommonFund?src=hashtag_click">#NIHCommonFund</a>
            site: <a dir="ltr" href="https://t.co/2fMYTdtQvi?amp=1">http://go.usa.gov/x7Vrn</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656/photo/1">
          <div>
            <img
                alt="Image announces a new program: The Cellular Senescence Network with URL commonfund.nih.gov/senescence"
                src="https://pbs.twimg.com/media/Epc-YHfVQAgNX89?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH Common Fund (@NIH_CommonFund) Heard about our Cellular Senescence Network ( #SenNet ) program? It aims to
        identify &amp; characterize senescent cells (which no longer replicate) across the body &amp; develop technology
        for studying #senescence . Read more on the #NIHCommonFund site: http:// go.usa.gov/x7Vrn
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDFunding/status/1339325291349479424"><span class="id">1339325291349479424</span>
        NIAID Funding <span class="user">@NIAIDFunding</span><span class="time">2020-12-16 17:43:27</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIAIDFunding/status/1339325291349479424">NIAID Funding (@NIAIDFunding)</a></b>
          <br>
          <div lang="en" dir="auto">
            Funding News <a dir="ltr" href="https://t.co/bcjwsHlr2m?amp=1">https://niaid.nih.gov/grants-contracts/funding-news‚Ä¶</a>.
            Review application and award data from FY 2020, when to submit just-in-time information, genomic data
            sharing requirements, new initiatives, policy changes, and more!
          </div>
        </div>
      </div>
      <div class="text">
        NIAID Funding (@NIAIDFunding) Funding News https:// niaid.nih.gov/grants-contrac ts/funding-news ‚Ä¶ . Review
        application and award data from FY 2020, when to submit just-in-time information, genomic data sharing
        requirements, new initiatives, policy changes, and more!
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1339308308977618947"><span class="id">1339308308977618947</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-16 16:35:58</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> NEWS: 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> has launched a study to evaluate short- and
            long-term health outcomes of <a dir="ltr" href="https://twitter.com/hashtag/SARSCoV2?src=hashtag_click">#SARSCoV2</a>
            infection in <a dir="ltr" href="https://twitter.com/hashtag/children?src=hashtag_click">#children</a>,
            including MIS-C, and to characterize immunologic pathways associated with different disease presentations
            and outcomes. <a dir="ltr" href="https://t.co/vnz0ivYn9E?amp=1">http://bit.ly/SARSCoV2inKids</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1339308308977618947/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EpYtnoMVoAADqZt?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        #COVID19 NEWS: @NIAIDNews has launched a study to evaluate short- and long-term health outcomes of #SARSCoV2
        infection in #children , including MIS-C, and to characterize immunologic pathways associated with different
        disease presentations and outcomes. http:// bit.ly/SARSCoV2inKids
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1338548949620158465"><span class="id">1338548949620158465</span> NIH <span
        class="user">@NIH</span><span class="time">2020-12-14 14:18:33</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH/status/1338548949620158465">NIH (@NIH)</a></b>
          <br>
          <div lang="en" dir="auto">
            Join us live on 12/15 at 2pm ET for a chat with <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a>
            Director Dr. Anthony Fauci &amp; <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a>
            Tribal Health Research Office Director Dr. David Wilson about the importance of 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> research, clinical
            trials &amp; vaccines within the <a dir="ltr" href="https://twitter.com/hashtag/AIAN?src=hashtag_click">#AIAN</a>
            community.
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH/status/1338548949620158465/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EpN7C3VUwAEUwk3?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH (@NIH) Join us live on 12/15 at 2pm ET for a chat with @NIAIDNews Director Dr. Anthony Fauci &amp; #NIH
        Tribal Health Research Office Director Dr. David Wilson about the importance of #COVID19 research, clinical
        trials &amp; vaccines within the #AIAN community.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1337460023807643648"><span class="id">1337460023807643648</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-11 14:11:33</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            COVID-19 NEWS: Today, a <a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click">#NIAID</a>
            study of <a dir="ltr" href="https://twitter.com/hashtag/baricitinib?src=hashtag_click">#baricitinib</a> and 
            <a dir="ltr" href="https://twitter.com/hashtag/remdesivir?src=hashtag_click">#remdesivir</a> for people
            hospitalized with <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a>
            published in <a dir="ltr" href="https://twitter.com/NEJM">@NEJM</a>. Participants who received the
            combination did better than those who received remdesivir alone. 
            <a dir="ltr" href="https://t.co/CxnUNNROy5?amp=1">http://bit.ly/ACTT2NEJM</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1337460023807643648/photo/1">
          <div>
            <img alt="A particle of the SARS-CoV-2 virus, isolated from a patient, colored yellow"
                src="https://pbs.twimg.com/media/Eo-cq4BXUAAcHjr?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        COVID-19 NEWS: Today, a #NIAID study of #baricitinib and #remdesivir for people hospitalized with #COVID19
        published in @NEJM . Participants who received the combination did better than those who received remdesivir
        alone. http:// bit.ly/ACTT2NEJM
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603847973679104"><span class="id">1334603847973679104</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-03 17:02:07</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            Natural infection with SARS-CoV-2 does not always lead to durable immunity to the virus. These results
            suggest that the mRNA-1273 vaccine could provide long-term protection.
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1334603847973679104/photo/1">
          <div>
            <img alt="Several round particles of SARS-CoV-2, the virus which causes COVID-19, colored blue."
                src="https://pbs.twimg.com/media/EoV2tqnXUAwFuOM?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        Natural infection with SARS-CoV-2 does not always lead to durable immunity to the virus. These results suggest
        that the mRNA-1273 vaccine could provide long-term protection.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603845993979906"><span class="id">1334603845993979906</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-03 17:02:07</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            Participants had sustained, elevated levels of 
            <a dir="ltr" href="https://twitter.com/hashtag/antibodies?src=hashtag_click">#antibodies</a> against the
            virus which causes <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a>,
            despite some decline in antibody titers over time. This suggests that the vaccine could provide durable
            humoral immunity against the virus.
          </div>
        </div>
      </div>
      <div class="text">
        Participants had sustained, elevated levels of #antibodies against the virus which causes #COVID19 , despite
        some decline in antibody titers over time. This suggests that the vaccine could provide durable humoral immunity
        against the virus.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603843649331203"><span class="id">1334603843649331203</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-03 17:02:06</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            The study tracked participants for 119 days after receiving their first dose of the vaccine; three months
            after the second dose. Blood tests were used to track the levels of antibodies against SARS-CoV-2, the virus
            which causes <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a>, in
            their blood.
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1334603843649331203/photo/1">
          <div>
            <img alt="An image showing a particle of SARS-CoV-2, the virus which causes COVID-19."
                src="https://pbs.twimg.com/media/EoV2bQFXYAM2HJy?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        The study tracked participants for 119 days after receiving their first dose of the vaccine; three months after
        the second dose. Blood tests were used to track the levels of antibodies against SARS-CoV-2, the virus which
        causes #COVID19 , in their blood.
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603841883566082"><span class="id">1334603841883566082</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-03 17:02:06</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            COVID-19 NEWS: In a letter published in <a dir="ltr" href="https://twitter.com/NEJM">@NEJM</a> today,
            researchers from <a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click">#NIAID</a> and
            partners describe the long-term immunogenicity results from a phase 1 trial of the mRNA-1273 
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a>
            <a dir="ltr" href="https://twitter.com/hashtag/vaccine?src=hashtag_click">#vaccine</a>:
          </div>
          <hr>
          <br><a href="https://t.co/CKWoz07Npd?amp=1">
          <div>
            <img alt src="https://pbs.twimg.com/card_img/1342161591744262144/1tZ72Ny7?format=jpg&name=240x240">
          </div>
          </a><a href="https://t.co/CKWoz07Npd?amp=1">
          <div>
            <div dir="auto">
              <b>Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM</b>
            </div>
            <div dir="auto">
              Correspondence from The New England Journal of Medicine ‚Äî Durability of Responses after SARS-CoV-2
              mRNA-1273 Vaccination
            </div>
            <div dir="auto">
              <i>nejm.org</i>
            </div>
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        COVID-19 NEWS: In a letter published in @NEJM today, researchers from #NIAID and partners describe the long-term
        immunogenicity results from a phase 1 trial of the mRNA-1273 #COVID19 #vaccine : Durability of Responses after
        SARS-CoV-2 mRNA-1273 Vaccination | NEJM Correspondence from The New England Journal of Medicine ‚Äî Durability
        of Responses after SARS-CoV-2 mRNA-1273 Vaccination nejm.org
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDFunding/status/1334193608078086144"><span class="id">1334193608078086144</span>
        NIAID Funding <span class="user">@NIAIDFunding</span><span class="time">2020-12-02 13:51:58</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIAIDFunding/status/1334193608078086144">NIAID Funding (@NIAIDFunding)</a></b>
          <br>
          <div lang="en" dir="auto">
            Funding News <a dir="ltr" href="https://t.co/bcjwsHD2qW?amp=1">https://niaid.nih.gov/grants-contracts/funding-news‚Ä¶</a>.
            Find advice on writing your application‚Äôs budget section, correctly labeling research roles, preparing for
            the new data sharing policy, and more!
          </div>
        </div>
      </div>
      <div class="text">
        NIAID Funding (@NIAIDFunding) Funding News https:// niaid.nih.gov/grants-contrac ts/funding-news ‚Ä¶ . Find
        advice on writing your application‚Äôs budget section, correctly labeling research roles, preparing for the new
        data sharing policy, and more!
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1334168788447596545"><span class="id">1334168788447596545</span> NIH <span
        class="user">@NIH</span><span class="time">2020-12-02 12:13:21</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH/status/1334168788447596545">NIH (@NIH)</a></b>
          <br>
          <div lang="en" dir="auto">
            Find <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a>
            <a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click">#COVID19</a> Phase 2 &amp; 3
            prevention and treatment <a dir="ltr" href="https://twitter.com/hashtag/clinicaltrials?src=hashtag_click">#clinicaltrials</a>
            as well as info on plasma &amp; blood donation on the <a dir="ltr" href="https://twitter.com/HHSGov">@HHSgov</a>
            web portal. Join the effort to find safe &amp; effective vaccines and treatments! 
            <a dir="ltr" href="https://t.co/d5IfjldG9h?amp=1">https://combatcovid.hhs.gov</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH/status/1334168788447596545/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EoPrXWTVgAAu3FA?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH (@NIH) Find #NIH #COVID19 Phase 2 &amp; 3 prevention and treatment #clinicaltrials as well as info on plasma
        &amp; blood donation on the @HHSgov web portal. Join the effort to find safe &amp; effective vaccines and
        treatments! https:// combatcovid.hhs.gov
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIDAnews/status/1333759426071769089"><span class="id">1333759426071769089</span>
        nidanews <span class="user">@NIDAnews</span><span class="time">2020-12-01 09:06:41</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIDAnews/status/1333759426071769089">nidanews (@NIDAnews)</a></b>
          <br>
          <div lang="en" dir="auto">
            This <a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click">#WorldAIDSDay</a>, NIDA
            Director Dr. Nora Volkow discusses drug use, sex and HIV ‚Äì and how coordination is critical in responding
            to the linked epidemics of <a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click">#HIV</a>
            and addiction.
            <br><a dir="ltr" href="https://t.co/w5hUrszV49?amp=1">https://loom.ly/KblaYr8</a>
            <br><a dir="ltr" href="https://twitter.com/hashtag/WAD2020?src=hashtag_click">#WAD2020</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIDAnews/status/1333759426071769089/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EoJ3IFjXUAA75oF?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        nidanews (@NIDAnews) This #WorldAIDSDay , NIDA Director Dr. Nora Volkow discusses drug use, sex and HIV ‚Äì and
        how coordination is critical in responding to the linked epidemics of #HIV and addiction. https://
        loom.ly/KblaYr8 #WAD2020
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333778025855528960"><span class="id">1333778025855528960</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-12-01 10:20:36</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            On <a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click">#WorldAIDSDay</a>, 
            <a dir="ltr" href="https://twitter.com/NIH">@NIH</a> reflects on both the remarkable progress that has been
            made against <a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click">#HIV</a> &amp; the
            considerable challenges that remain. Read a statement from 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> Director Dr. Fauci &amp; 
            <a dir="ltr" href="https://twitter.com/NIH_OAR">@NIH_OAR</a> Director Dr. Goodenow: 
            <a dir="ltr" href="https://t.co/z2zvEeUbLI?amp=1">https://bit.ly/NIHWAD2020</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1333778025855528960/photo/1">
          <div>
            <img alt="A man's hand holding a red HIV/AIDS awareness ribbon"
                src="https://pbs.twimg.com/media/EoKH0ewXcAAx6DV?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        On #WorldAIDSDay , @NIH reflects on both the remarkable progress that has been made against #HIV &amp; the
        considerable challenges that remain. Read a statement from @NIAIDNews Director Dr. Fauci &amp; @NIH_OAR Director
        Dr. Goodenow: https:// bit.ly/NIHWAD2020
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333507438063083523"><span class="id">1333507438063083523</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-11-30 16:25:23</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click">#HIV</a> NEWS: 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> today announced the investigators &amp;
            institutions that will lead 4 <a dir="ltr" href="https://twitter.com/NIH">@NIH</a> HIV 
            <a dir="ltr" href="https://twitter.com/hashtag/ClinicalTrials?src=hashtag_click">#ClinicalTrials</a>
            networks over the next 7 years. NIAID also awarded grants to 35 institutions selected as HIV clinical trials
            units. <a dir="ltr" href="https://t.co/5ztbXPSrgR?amp=1">https://bit.ly/HIVnetworks</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1333507438063083523/photo/1">
          <div>
            <img alt="Red ribbon for HIV/AIDS awareness"
                src="https://pbs.twimg.com/media/EoGR5f9XEAgTkwN?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        #HIV NEWS: @NIAIDNews today announced the investigators &amp; institutions that will lead 4 @NIH HIV
        #ClinicalTrials networks over the next 7 years. NIAID also awarded grants to 35 institutions selected as HIV
        clinical trials units. https:// bit.ly/HIVnetworks
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333493097745956864"><span class="id">1333493097745956864</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-11-30 15:28:24</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            <a dir="ltr" href="https://twitter.com/hashtag/PeanutAllergy?src=hashtag_click">#PeanutAllergy</a> NEWS: 
            <a dir="ltr" href="https://twitter.com/NIAIDNews">@NIAIDNews</a> is supporting a study to improve 
            <a dir="ltr" href="https://twitter.com/hashtag/pediatric?src=hashtag_click">#pediatric</a> clinicians‚Äô
            adherence to the Addendum Guidelines for the Prevention of 
            <a dir="ltr" href="https://twitter.com/hashtag/Peanut?src=hashtag_click">#Peanut</a>
            <a dir="ltr" href="https://twitter.com/hashtag/Allergy?src=hashtag_click">#Allergy</a> using an education
            module and a new tool in the Electronic Health Record. <a dir="ltr" href="https://t.co/iRXqvnjCOG?amp=1">https://clinicaltrials.gov/ct2/show/NCT04604431‚Ä¶</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1333493097745956864/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EoGEzxLVQAE7_eh?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        #PeanutAllergy NEWS: @NIAIDNews is supporting a study to improve #pediatric clinicians‚Äô adherence to the
        Addendum Guidelines for the Prevention of #Peanut #Allergy using an education module and a new tool in the
        Electronic Health Record. https:// clinicaltrials.gov/ct2/show/NCT04 604431 ‚Ä¶
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333476599367307269"><span class="id">1333476599367307269</span>
        NIAID News <span class="user">@NIAIDNews</span><span class="time">2020-11-30 14:22:50</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <div lang="en" dir="auto">
            NEWS: An experimental vaccine developed in Europe to prevent infection by 
            <a dir="ltr" href="https://twitter.com/hashtag/Crimean?src=hashtag_click">#Crimean</a> Congo hemorrhagic
            fever virus has protected cynomolgus macaques in a new NIAID collaborative study. 
            <a dir="ltr" href="https://t.co/SrGKY3mwac?amp=1">https://bit.ly/3o9F1dv</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIAIDNews/status/1333476599367307269/photo/1">
          <div>
            <img alt="Map showing where CCHFV is endemic"
                src="https://pbs.twimg.com/media/EoF1xQCVcAA-U_N?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NEWS: An experimental vaccine developed in Europe to prevent infection by #Crimean Congo hemorrhagic fever virus
        has protected cynomolgus macaques in a new NIAID collaborative study. https:// bit.ly/3o9F1dv
      </div>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH_OAR/status/1331614501028978691"><span class="id">1331614501028978691</span> NIH
        OAR <span class="user">@NIH_OAR</span><span class="time">2020-11-25 11:03:31</span></a>
      </div>
      <hr>
      <div class="content">
        <div>
          <b><a href="https://twitter.com/NIH_OAR/status/1331614501028978691">NIH OAR (@NIH_OAR)</a></b>
          <br>
          <div lang="en" dir="auto">
            Join <a dir="ltr" href="https://twitter.com/NIH_OAR">@NIH_OAR</a> December 1st at 11:00am for the virtual 
            <a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click">#NIH</a>
            <a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click">#WorldAIDSDay</a> observance 
            <a dir="ltr" href="https://t.co/9HB1rsxC0Q?amp=1">http://ow.ly/hTDr50CsIks</a>. Agenda &amp; speakers bios
            available <a dir="ltr" href="https://t.co/pjIPAYaqF3?amp=1">http://ow.ly/3PJN50CsIkr</a>. 
            <a dir="ltr" href="https://twitter.com/hashtag/WAD2020?src=hashtag_click">#WAD2020</a>
          </div>
          <hr>
          <br><a href="https://twitter.com/NIH_OAR/status/1331614501028978691/photo/1">
          <div>
            <img alt="Image" src="https://pbs.twimg.com/media/EnrYVQ2W8AAp29S?format=jpg&name=small">
          </div>
          </a>
        </div>
      </div>
      <div class="text">
        NIH OAR (@NIH_OAR) Join @NIH_OAR December 1st at 11:00am for the virtual #NIH #WorldAIDSDay observance http://
        ow.ly/hTDr50CsIks . Agenda &amp; speakers bios available http:// ow.ly/3PJN50CsIkr . #WAD2020
      </div>
    </div>
    <hr class="sep">
  </body>
</html>
